INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors
NAYA has also announced that five new board directors have joined its leadership team effective January 1st, 2024.
- NAYA has also announced that five new board directors have joined its leadership team effective January 1st, 2024.
- “NAYA is thrilled to welcome new board members with outstanding executive and entrepreneurial track records,” commented NAYA CEO Dr. Daniel Teper.
- She is currently Executive Engagement Lead at Publicis, the 2nd largest communications group in the world, where she launched multiple brands as Chief Marketing Officer.
- He previously held several leadership positions in corporate and business development and partnerships at Sanofi.